COVID-19 is the most devastating disease in recent times affecting most people globally.
The higher rate of transmissibility and mutations of SARS-CoV-2 along with the lack of …

Clinical and experimental data have shown that prolonged exposure to GCs leads to bone
loss and increases fracture risk. Special attention has been given to existing emerging drugs …

The textile industry, while of major importance in the world economy, is a toxic industry
utilizing and emitting thousands of chemical substances into the aquatic environment. The …

Anti-osteoporotic agents are clinically employed to improve bone health and prevent
osteoporotic fractures. In the current study, we investigated the potential of chitosan …

Osteopenia and osteoporosis are bone disorders characterized by reduced bone mineral
density (BMD), altered bone microarchitecture and increased bone fragility. Because of …

The advancement of human genomics has revolutionized our understanding of the genetic
architecture of many skeletal diseases, including osteoporosis. However, interpreting results …

Alzheimer's disease (AD) and osteoporosis (OP) are progressive degenerative diseases
caused by multiple factors, placing a huge burden on the world. Much evidence indicates …

This study delves into the potential of chito-oligosaccharides (COS) to promote osteoblast
differentiation and prevent osteoporosis, utilizing experiments with mouse MSCs and the …

Bone diseases may not be imminently life-threatening or a leading cause of death such as
heart diseases or cancers. However, as aging population grows in almost every part of the …

Women face a significant change in their reproductive health as menopause sets in. It is
marred with numerous physiological changes that negatively impact their quality of life. This …